1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"FAST California" is currently closed and not accepting applications.
FAST California is sponsored by California Life Sciences (CLS). The FAST California program provides founders of disruptive innovative life sciences companies with a customized advisory program. Companies are matched with industry experts for 12 weeks to build a compelling commercialization strategy, receive mentorship, and prepare to pitch to investors.
It's an equity-free program that helps early-stage companies in life sciences.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Early-stage life science companies based in or with a strong presence in California, with less than 12 employees, and having raised less than $5 million in dilutive funding. Confirm the full requirements in the official notice before applying.
The published deadline was July 6, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
FAST California is funded by California Life Sciences (CLS). Verify program details on the funder's official page before applying.
This opportunity targets applicants in California. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read articleAwards slashed by half, life sciences applicants rejected at 95%, and the White House steering which fields get funded. How the GRFP went from funding the person to funding the priority.
Read articleAfter a rare gap with zero active omnibus NOFOs, NIH has reissued its SBIR/STTR parent announcements — collapsing four solicitations into two, adding a Strategic Breakthrough bridge and a Commercialization Readiness Pilot, and reopening the funnel with a September 5, 2026 receipt date. Here are the exact solicitation numbers, the new budget ceilings, what actually changed, and how a small business should sequence its submission.
Read article